4D Molecular Therapeutics (FDMT) Stock: Buy, Sell, or Hold?
FDMT - 4D Molecular Therapeutics, Inc. Common Stock
$12.70
0.11 (0.87%)
▲
5d:
-8.24%
30d:
-10.44%
90d:
+3.17%
WAIT
LOW Confidence
Analysis Updated: Oct 8, 2026 12:00 AM ET
Earnings: Nov 09, 2026
30d
Get Alerted When FDMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FDMT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FDMT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: FDMT is currently trading at $12.70, which is considered oversold relative to its 30-day fair value range of $13.60 to $15.02.
Technical Outlook: Technically, FDMT is in a strong uptrend. Immediate support is located at $12.12, while resistance sits at $14.97.
Market Sentiment: FDMT scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.09 (+121.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FDMT is in a strong uptrend. Immediate support is located at $12.12, while resistance sits at $14.97.
Market Sentiment: FDMT scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.09 (+121.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.60 -
$15.02
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 121.2% below Wall St target ($28.09)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$13.60 -
$15.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.12
Resistance Level
$14.97
Current Trend
Strong Uptrend
Technical data as of
Oct 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.10
Wall Street Target
$28.09
(+121.2%)
Revenue Growth (YoY)
25106.7%
Profit Margin
-194.7%
Share & Embed Analysis
Last updated: October 08, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FDMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 75 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
23 analysts |
$257 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$74 | 51 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
